Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Current Deferred Revenue (2017 - 2025)

cbdMD's Current Deferred Revenue history spans 8 years, with the latest figure at $488626.0 for Q4 2025.

  • For Q4 2025, Current Deferred Revenue fell 7.36% year-over-year to $488626.0; the TTM value through Dec 2025 reached $488626.0, down 7.36%, while the annual FY2025 figure was $506289.0, 0.6% up from the prior year.
  • Current Deferred Revenue for Q4 2025 was $488626.0 at cbdMD, down from $506289.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $557353.0 in Q1 2025 and bottomed at $755.0 in Q2 2021.
  • The 4-year median for Current Deferred Revenue is $504771.5 (2024), against an average of $429667.4.
  • The largest annual shift saw Current Deferred Revenue soared 171.67% in 2024 before it decreased 7.43% in 2025.
  • A 4-year view of Current Deferred Revenue shows it stood at $755.0 in 2021, then soared by 24435.89% to $185246.0 in 2023, then soared by 184.72% to $527438.0 in 2024, then fell by 7.36% to $488626.0 in 2025.
  • Per Business Quant, the three most recent readings for YCBD's Current Deferred Revenue are $488626.0 (Q4 2025), $506289.0 (Q3 2025), and $509198.0 (Q2 2025).